BIOSYNTIA ApS: Financial statements 2021
CVR: 34892970
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,167,480 and a net result of DKK -10,062,482 compared with DKK -9,352,159 the year before. That is an increase of 42.7% compared with the year before. Equity in the 2021 report amounted to DKK 16,150,226. The solvency ratio was 47.1%. The company had 17 employees in the financial year.
- Gross Profit
- DKK 1,167,480
- Profit/Loss
- DKK -10,062,482
- Equity
- DKK 16,150,226
- Total Assets
- DKK 34,290,337
- Employees
- 17
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 1.2 mio. | -10.1 mio. | 16.2 mio. | 17 |
| 2020 | - | 818 t. | -9.4 mio. | 26.2 mio. | 21 |
| 2019 | - | 439 t. | -8.2 mio. | 16.9 mio. | 20 |
| 2018 | - | -2.7 mio. | -9.4 mio. | 25.2 mio. | 18 |
| 2017 | - | 2.2 mio. | -3.2 mio. | 4.8 mio. | 14 |
Official annual report
Find more companies like BIOSYNTIA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
BIOSYNTIA ApS has published its annual report for 2020. Gross profit came to DKK 818,132, and the net result was DKK -9,352,159.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The board consists of Henrik Dalbøge (chair), Joško Bobanović and Thomas Grotkjær. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity in the 2025 report amounted to DKK 32,860,576.